Leinco Technologies

BAFF-R (CT) Blocking Peptide

Product Code:
 
LEI-B504
Product Group:
 
Peptides
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-B504-50ug50 ug£216.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Related Products
  • Show All

Further Information

Concentration:
0.2 mg/ml
Format:
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Formulation:
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Long Description:
BAFF receptor (BAFFR) is a type III transmembrane protein and member of the TNF receptor (TNFR) super family. It is highly expressed in spleen, lymph node, B-cells and peripheral blood leukocytes. BAFFR plays a role in nearly all stages of differentiation of B-cells from development to the maintenance of long-lived bone marrow plasma cells. BAFFR signals by activation of the NF-kappaB signaling pathway. Overexpression of the BAFFR ligand, BAFF, in mice leads to autoimmune characteristics similar to systemic lupus erythematosus (SLE) and Sjogren?s syndrome. Furthermore, high levels of BAFF have been detected in the serum of humans with SLE, rheumatoid arthritis, Sjogren?s syndrome and systemic sclerosis. Inhibition of BAFFR signaling with BAFFR-Ig has been successful in treating SLE and rheumatoid arthritis in mouse models. In addition misexpression of BAFFR brought about by retroviral integration has lead to leukemia in some strains of mice. This makes BAFFR an obvious candidate for further therapeutic investigation. Recombinant human BAFFR has a molecular weight of 7.7 kDa and contains 76 amino acid residues corresponding to the extracellular portion of the full native BAFFR.
Target:
B-Cell Activating Factor Receptor

References

1. Tschopp J, Martinon F, and Burns K. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 2003; 4:95-104. 2. Bruey JM, Bruey-Sedano N, Newman R, et al. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-?B and caspase-1 activation in macrophages. J. Biol. Chem. 2004; 279:51897-907. 3. Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1?-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20:319-25. 4. Martinon F and Tschopp J. NLRs join TLRs as innate sensors of pathogens. TRENDS Imm. 2005; 26:447-54.